Aldeyra Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update

Go back to Aldeyra Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update

Aldeyra Therapeutics (ALDX) Reports Q1 Loss of $0.58/Share

May 9, 2019 7:17 AM EDT

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.58), versus ($0.43) reported last year.

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

... More